By Sandra Sather and Jennifer Lawyer
Since clinical trials have become increasingly complex with more data being collected, this consequently puts more pressure on sponsors to improve efficiencies while still maintaining quality.
Although CROs are commonly entrusted to handle the bulk of the clinical trial process, it’s still the sponsor’s responsibility to ensure the quality of that work. As such, sponsors need to proactively identify and manage the risks involved with working with a CRO. This kind of oversight can help reduce the likelihood of negative consequences that could impact the quality of a trial.